New Delhi: Moving to ensure there is no shortage of stents due to price control, the government has invoked an emergency provision making it mandatory for manufacturers to maintain production and supply of coronary stents at previous levels for at least six months.
\r\nStent makers and importers have also been directed to submit a weekly report on stents production and distribution to the National Pharmaceutical Pricing Authority (NPPA), which regulates prices of drugs and medical devices. |
